Raymond James Assumes Denali Therapeutics Inc. (DNLI) at Market Perform
Tweet Send to a Friend
Raymond James analyst Danielle Brill assumes coverage on Denali Therapeutics Inc. (NASDAQ: DNLI) with a Market Perform rating.The analyst commented ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
